fluconazole has been researched along with Urinary Tract Infections in 63 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Urinary Tract Infections: Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Since fluconazole achieves high urine concentrations, we assessed its usefulness in the treatment of urinary candidiasis." | 7.69 | [Fluconazole in treatment of urinary candidiasis. Experience with 24 patients]. ( Castrillón, MA; del Canto, E; Pino, M; Schenone, D; Thompson, L, 1995) |
| "Fungal urinary tract infections are increasingly prevalent in the elderly in acute and chronic care settings." | 6.68 | Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients. ( Fox, N; Freeman, K; Jacobs, LG; Lipschultz, D; Skidmore, EA, 1996) |
| "Whether echinocandins could be used to treat candidemia of a urinary tract source (CUTS) is unknown." | 5.46 | Echinocandins Compared to Fluconazole for Candidemia of a Urinary Tract Source: A Propensity Score Analysis. ( Aguado, JM; Almirante, B; Ayats, J; Blanco-Vidal, MJ; Cardozo, C; Carratalà, J; Cuervo, G; Fernández-Ruiz, M; Garcia-Vidal, C; González-Barberá, E; Gudiol, C; Manzur, A; Marco, F; Meije, Y; Montejo, JM; Muñoz, P; Pemán, J; Puig-Asensio, M; Vena, A, 2017) |
| "A patient with hepatitis experienced worsening of her liver function when treated with fluconazole for a Candida infection in her urine." | 4.79 | Worsening of liver function with fluconazole and review of azole antifungal hepatotoxicity. ( Gearhart, MO, 1994) |
| " Fluconazole is the agent of choice for most Candida urinary tract infections." | 3.85 | Comparison of Amphotericin B Bladder Irrigations Versus Fluconazole for the Treatment of Candiduria in Intensive Care Unit Patients. ( Campbell-Bright, S; Caylor, MM; Lin, FC; Sullivan, KA, 2017) |
| "We evaluated whether the likelihood of developing invasive candidiasis (IC) differed depending upon the anatomic site of Candida colonization in 182 surgical intensive care unit (SICU) patients who participated in a randomized trial of fluconazole to prevent candidiasis." | 3.73 | The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients. ( Hendrix, CW; Johnson, EA; Lipsett, PA; Magill, SS; Merz, WG; Pelz, RK; Swoboda, SM, 2006) |
| "Since fluconazole achieves high urine concentrations, we assessed its usefulness in the treatment of urinary candidiasis." | 3.69 | [Fluconazole in treatment of urinary candidiasis. Experience with 24 patients]. ( Castrillón, MA; del Canto, E; Pino, M; Schenone, D; Thompson, L, 1995) |
| "Two children with fungal urinary tract infections (UTI) were treated with fluconazole." | 3.69 | Fluconazole for treatment of fungal infections of the urinary tract in children. ( Mirza, I; Zia-ul-Miraj, M, 1997) |
| "Although fungal urinary tract infections are an increasing nosocomial problem, the significance of funguria is still not clear." | 2.69 | Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. ( Dismukes, WE; Gallis, HA; Karchmer, AW; Kauffman, CA; Lee, JY; Mangi, R; McKinsey, DS; Mosher, A; Sharkey, PK; Sobel, JD; Sugar, AM; Vazquez, JA; Wise, GJ, 2000) |
| "Oral fluconazole was safe and effective for short-term eradication of candiduria, especially following catheter removal." | 2.69 | Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. ( Dismukes, WE; Karchmer, AW; Kauffman, CA; Lee, J; McKinsey, D; Panzer, H; Sobel, JD; Thomas, C; Vazquez, JA; Zervos, M, 2000) |
| "Fungal urinary tract infections are increasingly prevalent in the elderly in acute and chronic care settings." | 2.68 | Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients. ( Fox, N; Freeman, K; Jacobs, LG; Lipschultz, D; Skidmore, EA, 1996) |
| "Fungal urinary tract infections are increasingly prevalent in hospitalized patients." | 2.68 | Oral fluconazole for Candida urinary tract infection. ( Castin, A; Moskovitz, B; Nativ, O; Potasman, I; Srugo, I, 1997) |
| "Most patients with sepsis or septic shock from a urinary source have complicated urinary tract infection." | 2.49 | Urinary tract infection. ( Nicolle, LE, 2013) |
| "Endogenous fungal endophthalmitis is a potentially blinding condition that can signal an underlying systemic infection." | 2.44 | Presumed Candida endogenous fungal endophthalmitis: a case report and literature review. ( Najmi, NG; Ober, RR; Song, HF, 2007) |
| "Fluconazole is approved for the treatment of candidal UTIs, but dosage recommendations are not consistent." | 2.41 | Fluconazole dose recommendation in urinary tract infection. ( Boedeker, KS; Kilzer, WJ, 2001) |
| "Cryptococcosis is an important opportunistic infection of organ transplant recipients." | 1.48 | Cryptococcoma of a transplanted kidney in a patient presenting with recurrent urinary tract infection: a case report. ( Greeff, L; Karusseit, VOL; Lengano, T; Muranda, AZ; Sathekge, MM, 2018) |
| "Whether echinocandins could be used to treat candidemia of a urinary tract source (CUTS) is unknown." | 1.46 | Echinocandins Compared to Fluconazole for Candidemia of a Urinary Tract Source: A Propensity Score Analysis. ( Aguado, JM; Almirante, B; Ayats, J; Blanco-Vidal, MJ; Cardozo, C; Carratalà, J; Cuervo, G; Fernández-Ruiz, M; Garcia-Vidal, C; González-Barberá, E; Gudiol, C; Manzur, A; Marco, F; Meije, Y; Montejo, JM; Muñoz, P; Pemán, J; Puig-Asensio, M; Vena, A, 2017) |
| "Candidiasis is still of major concern in neonates with accompanying risk factors." | 1.38 | Candidiasis caused by Candida kefyr in a neonate: case report. ( Dietz, A; Geginat, G; Kilian, AK; Reinshagen, K; Schroten, H; Tenenbaum, T; Weichert, S; Zahn, K, 2012) |
| "Fluconazole was the antifungal agent most frequently used, both in infected and colonized patients." | 1.32 | [Indications for antifungal treatment in intensive care unit patients]. ( Alvarez-Lerma, F; Bermejo, B; Cerdá, E; León, C; Olaechea, P; Palomar, M, 2004) |
| "Fluconazole was most frequently utilized (n = 42, 52." | 1.30 | Clinicians' reaction to positive urine culture for Candida organisms. ( Ayeni, O; Khatib, R; Riederer, KM; Wilson, FM, 1999) |
| "Fluconazole is an effective oral or intravenous anti-fungal agent." | 1.29 | Fluconazole infused via a nephrostomy tube: a novel and effective route of delivery. ( Oliver, SE; Walker, RJ; Woods, DJ, 1995) |
| "Fluconazole was given either orally (4 patients) or intravenously (3 patients) in a dose of 50 mg per day." | 1.28 | [Clinical efficacy of fluconazole in urinary tract fungal infections]. ( Nito, H, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.59) | 18.7374 |
| 1990's | 19 (30.16) | 18.2507 |
| 2000's | 17 (26.98) | 29.6817 |
| 2010's | 23 (36.51) | 24.3611 |
| 2020's | 3 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Oladele, RO | 1 |
| Ettu, AO | 1 |
| Medugu, N | 1 |
| Habib, A | 1 |
| Egbagbe, E | 1 |
| Osinaike, T | 1 |
| Makanjuola, OB | 1 |
| Ogunbosi, B | 1 |
| Irowa, OO | 1 |
| Ejembi, J | 1 |
| Uwaezuoke, NS | 1 |
| Adeleke, G | 1 |
| Mutiu, B | 1 |
| Ogunsola, F | 1 |
| Rotimi, V | 1 |
| Rodríguez Arias, EA | 1 |
| Santoya Espinosa, LC | 1 |
| Romano, JP | 1 |
| Mota, MF | 1 |
| Chabay, P | 1 |
| Diaz Aguiar, P | 1 |
| Gharaghani, M | 1 |
| Rezaei-Matehkolaei, A | 1 |
| Hardani, AK | 1 |
| Zarei Mahmoudabadi, A | 1 |
| Cuervo, G | 1 |
| Garcia-Vidal, C | 1 |
| Puig-Asensio, M | 1 |
| Vena, A | 1 |
| Meije, Y | 1 |
| Fernández-Ruiz, M | 1 |
| González-Barberá, E | 1 |
| Blanco-Vidal, MJ | 1 |
| Manzur, A | 1 |
| Cardozo, C | 1 |
| Gudiol, C | 1 |
| Montejo, JM | 1 |
| Pemán, J | 1 |
| Ayats, J | 1 |
| Aguado, JM | 1 |
| Muñoz, P | 1 |
| Marco, F | 1 |
| Almirante, B | 1 |
| Carratalà, J | 1 |
| Tasneem, U | 1 |
| Siddiqui, MT | 1 |
| Faryal, R | 1 |
| Shah, AA | 1 |
| Lima, GME | 1 |
| Nunes, MO | 1 |
| Chang, MR | 1 |
| Tsujisaki, RAS | 1 |
| Nunes, JO | 1 |
| Taira, CL | 1 |
| Thomaz, DY | 1 |
| Negro, GMBD | 1 |
| Mendes, RP | 1 |
| Paniago, AMM | 1 |
| Alobaid, K | 1 |
| Faty, M | 1 |
| El-Nahas, A | 1 |
| Al-Terki, A | 1 |
| Khan, Z | 1 |
| Muranda, AZ | 1 |
| Greeff, L | 1 |
| Sathekge, MM | 1 |
| Lengano, T | 1 |
| Karusseit, VOL | 1 |
| Xiang, YY | 1 |
| Lv, Y | 1 |
| Guo, R | 1 |
| Xue, J | 1 |
| Pérez-Lanzac, A | 1 |
| Soto-Villalva, J | 1 |
| Ledo-Cepero, MJ | 1 |
| Garcia-Baquero, R | 1 |
| Rosety-Rodriguez, J | 1 |
| Madurga-Patuel, B | 1 |
| Alvarez-Ossorio-Fernández, JL | 1 |
| Osawa, K | 1 |
| Shigemura, K | 1 |
| Yoshida, H | 1 |
| Fujisawa, M | 1 |
| Arakawa, S | 1 |
| Nicolle, LE | 1 |
| Wernli, L | 1 |
| Bonkat, G | 1 |
| Gasser, TC | 1 |
| Bachmann, A | 1 |
| Braissant, O | 1 |
| Jakubowska, A | 1 |
| Kiliś-Pstrusińska, K | 1 |
| Pukajło-Marczyk, A | 1 |
| Samir, S | 1 |
| Bagłaj, M | 1 |
| Zwolińska, D | 1 |
| Sulaiman, SP | 1 |
| Singh, R | 1 |
| Mandal, J | 1 |
| Garcia, H | 1 |
| Guitard, J | 1 |
| Peltier, J | 1 |
| Tligui, M | 1 |
| Benbouzid, S | 1 |
| Elhaj, SA | 1 |
| Rondeau, E | 1 |
| Hennequin, C | 1 |
| Kaur, R | 1 |
| Garg, T | 1 |
| Goyal, AK | 1 |
| Rath, G | 1 |
| Ding, CH | 1 |
| Wahab, AA | 1 |
| Muttaqillah, NA | 1 |
| Tzar, MN | 1 |
| Toner, L | 1 |
| Papa, N | 1 |
| Aliyu, SH | 1 |
| Dev, H | 1 |
| Lawrentschuk, N | 1 |
| Al-Hayek, S | 1 |
| Sullivan, KA | 1 |
| Caylor, MM | 1 |
| Lin, FC | 1 |
| Campbell-Bright, S | 1 |
| Toka Özer, T | 1 |
| Durmaz, S | 1 |
| Yula, E | 1 |
| Salemis, NS | 1 |
| Tsolakis, K | 1 |
| Aloizos, S | 1 |
| Tsohataridis, E | 1 |
| Ruan, SY | 1 |
| Chien, JY | 1 |
| Hsueh, PR | 1 |
| Tuon, FF | 1 |
| Amato, VS | 1 |
| Penteado Filho, SR | 1 |
| Yüksekkaya, S | 1 |
| Fındık, D | 1 |
| Arslan, U | 1 |
| Fisher, JF | 1 |
| Sobel, JD | 4 |
| Kauffman, CA | 3 |
| Newman, CA | 1 |
| Ozhak-Baysan, B | 1 |
| Ogunc, D | 1 |
| Colak, D | 1 |
| Ongut, G | 1 |
| Donmez, L | 1 |
| Vural, T | 1 |
| Gunseren, F | 1 |
| Sundi, D | 1 |
| Tseng, K | 1 |
| Mullins, JK | 1 |
| Marr, KA | 1 |
| Hyndman, ME | 1 |
| Weichert, S | 1 |
| Reinshagen, K | 1 |
| Zahn, K | 1 |
| Geginat, G | 1 |
| Dietz, A | 1 |
| Kilian, AK | 1 |
| Schroten, H | 1 |
| Tenenbaum, T | 1 |
| Triolo, V | 1 |
| Gari-Toussaint, M | 1 |
| Casagrande, F | 1 |
| Garraffo, R | 1 |
| Dageville, C | 1 |
| Boutté, P | 1 |
| Bérard, E | 1 |
| Puerto, JL | 1 |
| García-Martos, P | 1 |
| Saldarreaga, A | 1 |
| Ruiz-Aragón, J | 1 |
| García-Agudo, R | 1 |
| Aoufi, S | 1 |
| Alvarez-Lerma, F | 2 |
| Nolla, J | 1 |
| Palomar, M | 2 |
| León, MA | 1 |
| Silva, V | 1 |
| Zepeda, G | 1 |
| Alvareda, D | 1 |
| León, C | 1 |
| Olaechea, P | 1 |
| Cerdá, E | 1 |
| Bermejo, B | 1 |
| Vázquez-Tsuji, O | 1 |
| Campos-Rivera, T | 1 |
| Ahumada-Mendoza, H | 1 |
| Rondán-Zárate, A | 1 |
| Martínez-Barbabosa, I | 1 |
| Magill, SS | 1 |
| Swoboda, SM | 1 |
| Johnson, EA | 1 |
| Merz, WG | 1 |
| Pelz, RK | 1 |
| Lipsett, PA | 1 |
| Hendrix, CW | 1 |
| Etienne, M | 1 |
| Caron, F | 1 |
| Najmi, NG | 1 |
| Song, HF | 1 |
| Ober, RR | 1 |
| Karabak, BI | 1 |
| Popov, SV | 1 |
| Shmel'kov, IIu | 1 |
| Ansari, SH | 1 |
| Levin, MH | 1 |
| Lipshitz, S | 1 |
| Hitchcock, RJ | 1 |
| Pallett, A | 1 |
| Hall, MA | 1 |
| Malone, PS | 1 |
| Gearhart, MO | 1 |
| Simşek, U | 1 |
| Akinci, H | 1 |
| Oktay, B | 1 |
| Kavrama, I | 1 |
| Ozyurt, M | 1 |
| Johnson, JR | 1 |
| Nassoura, Z | 1 |
| Ivatury, RR | 1 |
| Simon, RJ | 1 |
| Jabbour, N | 1 |
| Stahl, WM | 1 |
| Thompson, L | 1 |
| Pino, M | 1 |
| Castrillón, MA | 1 |
| Schenone, D | 1 |
| del Canto, E | 1 |
| Jacobs, LG | 1 |
| Skidmore, EA | 1 |
| Freeman, K | 1 |
| Lipschultz, D | 1 |
| Fox, N | 1 |
| Oliver, SE | 1 |
| Walker, RJ | 1 |
| Woods, DJ | 1 |
| Ratajczak, B | 1 |
| Wierzba, J | 1 |
| Irga, N | 2 |
| Czarniak, P | 1 |
| Kosiak, W | 1 |
| Samet, A | 1 |
| Chabior, M | 1 |
| Filipowicz, J | 1 |
| Kozłowski, M | 1 |
| Szalewska, M | 1 |
| Zurowska, A | 1 |
| Slusarczyk, M | 1 |
| Zia-ul-Miraj, M | 1 |
| Mirza, I | 1 |
| Schwab, U | 1 |
| Chernomas, F | 1 |
| Larcom, L | 1 |
| Weems, J | 1 |
| Potasman, I | 1 |
| Castin, A | 1 |
| Moskovitz, B | 1 |
| Srugo, I | 1 |
| Nativ, O | 1 |
| Menéndez López, V | 1 |
| Elia López, M | 1 |
| Llorens Martínez, FJ | 1 |
| Galán Llopis, JA | 1 |
| de Nova Sánchez, E | 1 |
| García López, F | 1 |
| Ayeni, O | 1 |
| Riederer, KM | 1 |
| Wilson, FM | 1 |
| Khatib, R | 1 |
| Gubbins, PO | 1 |
| McConnell, SA | 1 |
| Penzak, SR | 1 |
| Vazquez, JA | 2 |
| Gallis, HA | 1 |
| McKinsey, DS | 1 |
| Karchmer, AW | 2 |
| Sugar, AM | 1 |
| Sharkey, PK | 1 |
| Wise, GJ | 1 |
| Mangi, R | 1 |
| Mosher, A | 1 |
| Lee, JY | 1 |
| Dismukes, WE | 2 |
| McKinsey, D | 1 |
| Zervos, M | 1 |
| Lee, J | 1 |
| Thomas, C | 1 |
| Panzer, H | 1 |
| Boedeker, KS | 1 |
| Kilzer, WJ | 1 |
| Dani, C | 1 |
| Bertini, G | 1 |
| Pezzati, M | 1 |
| Tacker, JR | 1 |
| Nito, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment (The CANTREAT Study): A Prospective, Randomized, Double Blind, Placebo Controlled Pilot Study[NCT00934934] | Phase 2 | 61 participants (Actual) | Interventional | 2010-04-30 | Terminated (stopped due to slow enrollment) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Sequential organ failure assessment. 0-24 The higher the number the more severe organ failure (NCT00934934)
Timeframe: post randomization
| Intervention | score on a scale (Mean) |
|---|---|
| Placebo | 5.9 |
| Antifungal | 5.9 |
Number of days free of antibiotic use within the first 28 days (NCT00934934)
Timeframe: 28 days
| Intervention | days (Median) |
|---|---|
| Placebo | 16 |
| Antifungal | 10 |
(NCT00934934)
Timeframe: 28 days
| Intervention | pg/ml (Mean) |
|---|---|
| VAP withCandida | 116 |
| VAP Without Candida | 129.1 |
(NCT00934934)
Timeframe: 28 days
| Intervention | mg/l (Mean) |
|---|---|
| VAP withCandida | 133 |
| VAP Without Candida | 145.7 |
Measure of the duration of participant stay in the ICU (NCT00934934)
Timeframe: 28 days
| Intervention | days (Median) |
|---|---|
| Placebo | 11.5 |
| Antifungal | 13 |
Measure of the duration of the participant's hospital stay (NCT00934934)
Timeframe: 90 days
| Intervention | days (Median) |
|---|---|
| Placebo | 29 |
| Antifungal | 28 |
Number of days free of ICU (NCT00934934)
Timeframe: 28 days
| Intervention | days (Median) |
|---|---|
| Placebo | 14 |
| Antifungal | 4 |
(NCT00934934)
Timeframe: 28 days
| Intervention | pg/ml (Mean) |
|---|---|
| VAP withCandida | 97.5 |
| VAP Without Candida | 3 |
Overall recruitment rate per site (NCT00934934)
Timeframe: 32 months
| Intervention | participants per site /month (Number) |
|---|---|
| Overall | 0.6 |
(NCT00934934)
Timeframe: 28 days
| Intervention | ng/ml (Mean) |
|---|---|
| VAP withCandida | 3.0 |
| VAP Without Candida | 22.5 |
Number of days in ICU free of ventilation (NCT00934934)
Timeframe: 28 days
| Intervention | days (Median) |
|---|---|
| Placebo | 8 |
| Antifungal | 9 |
9 reviews available for fluconazole and Urinary Tract Infections
| Article | Year |
|---|---|
Renal fungus ball in a patient with retroperitoneal fibrosis: Unique complication in a rare disease.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Disease Management; Fluconazole; Humans; Ki | 2018 |
[Effect of bladder irrigation with amphotericin B for treatment of urinary tract fungal infection: a meta-analysis].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Mycoses; Randomized Controlled Trials as Top | 2018 |
Urinary tract infection.
Topics: Acute Disease; Aminoglycosides; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Catheters, | 2013 |
Bladder irrigation with amphotericin B and fungal urinary tract infection--systematic review with meta-analysis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Randomized Cont | 2009 |
[Management of fungal urinary tract infections].
Topics: Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Cystitis; D | 2007 |
Presumed Candida endogenous fungal endophthalmitis: a case report and literature review.
Topics: Administration, Oral; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Drug | 2007 |
Worsening of liver function with fluconazole and review of azole antifungal hepatotoxicity.
Topics: Administration, Oral; Alanine Transaminase; Aspartate Aminotransferases; Candidiasis; Chemical and D | 1994 |
Current management of funguria.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole; Humans; Male; | 1999 |
Fluconazole dose recommendation in urinary tract infection.
Topics: Antifungal Agents; Candidiasis; Clinical Trials as Topic; Fluconazole; Humans; Mycoses; Urinary Trac | 2001 |
6 trials available for fluconazole and Urinary Tract Infections
| Article | Year |
|---|---|
Fluconazole therapy for Candida albicans urinary tract infections in infants.
Topics: Antifungal Agents; Bezoars; Candidiasis; Fluconazole; Follow-Up Studies; Humans; Infant; Infant, New | 2002 |
Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy.
Topics: Adult; Aged; Amphotericin B; Bacterial Infections; Candidiasis; Cause of Death; Colony Count, Microb | 1993 |
Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amphotericin B; Candidiasis; Combined Modality Therap | 1996 |
Oral fluconazole for Candida urinary tract infection.
Topics: Administration, Oral; Aged; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole; Hu | 1997 |
Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Catheterization; Cross Infection; Female; F | 2000 |
Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group.
Topics: Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis; Double-Blind Method; Female; Flucon | 2000 |
48 other studies available for fluconazole and Urinary Tract Infections
| Article | Year |
|---|---|
Antibiotic Guidelines for Critically Ill Patients in Nigeria.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clavulanic Acid; Community-Acqu | 2023 |
[Bilateral multifocal kidney abscess due to Candida albicans].
Topics: Abscess; Adult; Antifungal Agents; Candida albicans; Child; Female; Fluconazole; Humans; Kidney; Kid | 2023 |
Genotypic diversity and antifungal susceptibility pattern of Candida albicans species isolated from hospitalized paediatric patients with urinary tract infection in Iran.
Topics: Antifungal Agents; Candida; Candida albicans; Child; Drug Resistance, Fungal; Fluconazole; Genotype; | 2021 |
Echinocandins Compared to Fluconazole for Candidemia of a Urinary Tract Source: A Propensity Score Analysis.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida albicans; Candida glabrata; Candidemia; Cohort S | 2017 |
Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; C | 2017 |
Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Dru | 2017 |
Cryptococcoma of a transplanted kidney in a patient presenting with recurrent urinary tract infection: a case report.
Topics: Adult; Antifungal Agents; Bacterial Infections; Biopsy; Coinfection; Cryptococcosis; Cryptococcus ne | 2018 |
Transumbilical single port surgery with conventional laparoscopic instruments in horseshoe kidney.
Topics: Adolescent; Antifungal Agents; Candidiasis; Dilatation, Pathologic; Equipment Design; Female; Flucon | 2013 |
Candida urinary tract infection and Candida species susceptibilities to antifungal agents.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Flucytosine; Hospita | 2013 |
Use of isothermal microcalorimetry to quantify the influence of glucose and antifungals on the growth of Candida albicans in urine.
Topics: Amphotericin B; Antifungal Agents; Calorimetry; Candida albicans; Fluconazole; Flucytosine; Glucose; | 2013 |
Fungal urinary tract infection complicated by acute kidney injury in an infant with intestino-vesical fistula.
Topics: Acute Kidney Injury; Bacterial Infections; Fluconazole; Humans; Infant; Injections, Intravenous; Int | 2013 |
Fungal profile of funguria cases at a tertiary care hospital in southern India.
Topics: Adult; Candida; Drug Resistance, Fungal; Female; Fluconazole; Humans; India; Male; Middle Aged; Tert | 2014 |
Caspofungin irrigation through percutaneous calicostomy catheter combined with oral flucytosine to treat fluconazole-resistant symptomatic candiduria.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Combined Modalit | 2015 |
Development, Optimization and Evaluation of Electrospun Nanofibers: Tool for Targeted Vaginal Delivery of Antimicrobials Against Urinary Tract Infections.
Topics: Adhesiveness; Administration, Intravaginal; Animals; Anti-Bacterial Agents; Calorimetry, Differentia | 2016 |
Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cross-Sectional Studies; Dose-Resp | 2014 |
Candida growth in urine cultures: a contemporary analysis of species and antifungal susceptibility profiles.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole | 2016 |
Comparison of Amphotericin B Bladder Irrigations Versus Fluconazole for the Treatment of Candiduria in Intensive Care Unit Patients.
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Cross Infection; | 2017 |
Antifungal susceptibilities of Candida species isolated from urine culture.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Female; Flu | 2016 |
Multiple septic complications of disseminated candidiasis following anorectal sepsis in a non-immunocompromised patient.
Topics: Aged, 80 and over; Antifungal Agents; Anus Diseases; Candida albicans; Candidiasis; Epididymitis; Fl | 2008 |
Persistent Candida parapsilosis funguria associated with an indwelling urinary tract stent for more than 7 years.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Mid | 2008 |
[Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; DNA, Fungal; Female; Fluconazole; Humans; I | 2011 |
Candida urinary tract infections--treatment.
Topics: Algorithms; Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Candidiasis, Invasive; | 2011 |
Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Child; Child, P | 2012 |
Invasive fungal bezoar requiring partial cystectomy.
Topics: Aged; Amphotericin B; Antifungal Agents; Bezoars; Candidiasis; Combined Modality Therapy; Cystectomy | 2012 |
Candidiasis caused by Candida kefyr in a neonate: case report.
Topics: Amphotericin B; Antifungal Agents; Anus, Imperforate; Candida; Candidiasis; Congenital Abnormalities | 2012 |
First report of urinary tract infection due to Pichia ohmeri.
Topics: Aged; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Male; Mycoses; Pichia; Specie | 2002 |
[Treatment approach for fungal infections in critically ill patients admitted to intensive care units: results of a multicenter survey].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Case Management; Consensus Development Conferences a | 2003 |
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Res | 2003 |
[Indications for antifungal treatment in intensive care unit patients].
Topics: Antifungal Agents; APACHE; Candidiasis; Comorbidity; Critical Care; Cross Infection; Fluconazole; Fu | 2004 |
Renal ultrasonography and detection of pseudomycelium in urine as means of diagnosis of renal fungus balls in neonates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Humans; Infant, Newbor | 2005 |
The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; APACHE; Candida; Candidiasis; Critica | 2006 |
[Fungal infections of the lower urinary tracts in urological patients].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Cryptococcosis; Female; Fluconazole; | 2007 |
Re: Fluconazole treatment in Torulopsis glabrata upper urinary tract infection causing ureteral obstruction.
Topics: Adult; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Ureteral Obstruction; Urinary Tr | 1995 |
Urinary tract candidiasis in neonates and infants.
Topics: Amphotericin B; Candidiasis; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Male | 1995 |
Treatment of catheter-associated Candiduria with fluconazole irrigation.
Topics: Adult; Aged; Aged, 80 and over; Candida; Candidiasis; Equipment Contamination; Female; Fluconazole; | 1995 |
Should all catheterized patients with candiduria be treated?
Topics: Amphotericin B; Candidiasis; Female; Fluconazole; Humans; Therapeutic Irrigation; Urinary Bladder; U | 1993 |
[Fluconazole in treatment of urinary candidiasis. Experience with 24 patients].
Topics: Adult; Aged; Aged, 80 and over; Candidiasis; Female; Fluconazole; Humans; Male; Middle Aged; Pyuria; | 1995 |
Fluconazole infused via a nephrostomy tube: a novel and effective route of delivery.
Topics: Aged; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Nephrostomy, Percutaneous; Renal | 1995 |
[The clinical course of fungal urinary tract infection in neonates].
Topics: Antifungal Agents; Candida albicans; Fluconazole; Flucytosine; Humans; Infant, Newborn; Ultrasonogra | 1996 |
[Acute renal insufficiency during Candida albicans candidiasis in a 2-month old infant].
Topics: Acute Kidney Injury; Candidiasis; Fluconazole; Humans; Infant; Infusions, Intravenous; Male; Ultraso | 1997 |
Fluconazole for treatment of fungal infections of the urinary tract in children.
Topics: Antifungal Agents; Fluconazole; Humans; Infant; Infant, Newborn; Male; Mycoses; Urinary Tract Infect | 1997 |
Molecular typing and fluconazole susceptibility of urinary Candida glabrata isolates from hospitalized patients.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Humans; Karyotyping; Microbia | 1997 |
[Treatment of pelvis fungus ball with ureteral catheterization, fluconazole, and urine alkalinization].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Bicarbonates; Candidiasis; Fluconazole; Humans; Kidney P | 1999 |
Management of asymptomatic candiduria.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Cross Infection; Fluconazo | 1999 |
Clinicians' reaction to positive urine culture for Candida organisms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Attitude of Health Pe | 1999 |
Fluconazole prophylaxis against fungal infection in preterm infants.
Topics: Antifungal Agents; Candida; Diagnostic Errors; Fluconazole; Humans; Infant, Newborn; Infant, Prematu | 2002 |
Successful use of fluconazole for treatment of urinary tract fungal infections.
Topics: Aged; Aged, 80 and over; Candidiasis; Fluconazole; Humans; Male; Middle Aged; Remission Induction; U | 1992 |
[Clinical efficacy of fluconazole in urinary tract fungal infections].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Drug Evaluatio | 1989 |